Vilya
Vilya uses AI-driven computational design to generate novel macrocycle drugs for human diseases. Its medicines are designed to combine the target precision of biologics with the convenience of oral dosing, including for diseases that are difficult to treat with existing drugs.
Facts
- HQ
- Seattle, Washington, USA
- Sectors
- Biotechnology, Drug discovery, Artificial intelligence
- Founders
- David Baker, Gaurav Bhardwaj, Lance Stewart, Patrick Salveson, Adam Moyer, Nao Hiranuma
Is this your organization? Claim it
Investor Spotlight: Chris Picardo on Cross-Disciplinary Innovation and Finding Unique Founders
In this episode of Founded & Funded, host Coral Garnick Ducken interviews Madrona Partner Chris Picardo for the latest Investor Spotlight. With degrees in math and English, Chris shares his unique journey into venture capital. Chris highlights the importance of cross-disciplinary skills in understanding and communicating complex concepts and what he looks for in founders, emphasizing unique worldviews and innovative approaches, particularly in AI, biotech, and consumer verticals. This is a great episode for entrepreneurs interested in working with VCs. (00:00) Introduction to Madrona Partner Chris Picardo (00:46) Chris Picardo: From Math and English to Startups (01:26) Chris's Transition to…
week of june 10: Greg Kunst - Aurion Biotech
Top Stories 1. Microsoft CEO leaves Starbucks board Geekwire article 2. Seattle startup wins lawsuit against Boeing Seattle Times article 3. VC backed biotech Vilya raises $71M Geekwire article 4. Lightrail SLU location debate Opinion 1: The Stranger article Opinion 2: PSBJ article 5. New record store on Vashon Seattle Times article About guest co-host Greg Kunst - Founder & CEO, Aurion Biotech: Greg Kunst founded Aurion Biotech which is a company that develops cell therapies for the treatment of serious eye disorders. He is on the board of Pr3vent, Inc tackling vision health for babies. He's strategic advisor for…